Kepler Capital analyst Christian Faitz maintained a Buy rating on Clariant AG (CLZNF – Research Report) on November 4 and set a price target of CHF15.00. The company’s shares closed last Monday at $13.89.
According to TipRanks, Faitz is a 4-star analyst with an average return of 8.1% and a 50.73% success rate.
Clariant AG has an analyst consensus of Moderate Buy, with a price target consensus of $17.12, a 23.29% upside from current levels. In a report released on October 30, UBS also maintained a Buy rating on the stock with a CHF16.00 price target.
CLZNF market cap is currently $4.63B and has a P/E ratio of 49.81.
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
Clariant AG (CLZNF) Company Description:
Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals. It operates through the following segments: Care Chemicals; Catalysis; Natural Resources;Plastics and Coatings; and Corporate. The Care Chemicals segment comprises the industrial and consumer specialties business unit (BU), food additives as well as the industrial biotechnology business. The Catalysis segment develops, manufactures, and sells a catalyst product for the chemical, fuel, and automotive industries. The Natural Resources segment comprises BUs oil and mining services and functional minerals. The Plastics and Coatings segment includes the BUs additives, pigments, and masterbatches. The company was founded in 1995 and is headquartered in Muttenz, Switzerland.
